Literature DB >> 2482334

Radiolabelling of Mycobacterium avium oligosaccharide determinant and use in macrophage studies.

J L Woodbury1, W W Barrow.   

Abstract

Internal radiolabelling procedures were used to radiolabel the oligosaccharide determinant of the glycopeptidolipids (GPL) from serovars 4 and 20 of the Mycobacterium avium complex. Mycobacteria were cultured in the presence of [6-3H]fucose, [2-3H]mannose or [methyl-3H]methionine, after which radiolabelled native lipid was extracted and distribution of radioactivity in native and deacetylated lipid was determined by thin-layer chromatographic methods. Incorporation of radiolabel was confirmed by examining acid hydrolysates of purified GPL for 3H-labelled sugars on cellulose thin-layer plates. Least incorporation of radiolabel into GPL was observed with [6-3H]fucose, whereas better incorporation was obtained with [2-3H]mannose and [methyl-3H]methionine. Use of [methyl-3H]methionine resulted in the radiolabelling of the methylated sugars in both the oligosaccharide determinant and the 3,4-di-O-methylrhamnose located at the terminus of the peptide core. Use of [2-3H]mannose resulted in the incorporation of radioactivity into the oligosaccharide determinant as 2-O-methylfucose, found in the GPL of both serovars 4 and 20. GPL radiolabelled with [2-3H]mannose were subsequently examined in macrophage cultures and found to be relatively inert to degradation by those phagocytic cells. These results substantiate earlier findings with the GPL of serovar 20 and indicate that these mycobacterial components may play a role in pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2482334     DOI: 10.1099/00221287-135-7-1875

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  9 in total

1.  Cell-free system responsible for internal radiolabeling of glycopeptidolipids of the Mycobacterium avium complex.

Authors:  N Ramasesh; E L Wright; W W Barrow
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  Modified lymphocyte response to mitogens induced by the lipopeptide fragment derived from Mycobacterium avium serovar-specific glycopeptidolipids.

Authors:  S K Tassell; M Pourshafie; E L Wright; M G Richmond; W W Barrow
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

3.  Molecular packing of cord factor and its interaction with phosphatidylinositol in mixed monolayers.

Authors:  R Almog; C A Mannella
Journal:  Biophys J       Date:  1996-12       Impact factor: 4.033

4.  Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8.

Authors:  W W Barrow; T L Davis; E L Wright; V Labrousse; M Bachelet; N Rastogi
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

5.  Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium.

Authors:  W W Barrow; E L Wright; K S Goh; N Rastogi
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

6.  Comparative effects of Mycobacterium avium glycopeptidolipid and lipopeptide fragment on the function and ultrastructure of mononuclear cells.

Authors:  M Pourshafie; Q Ayub; W W Barrow
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

7.  Immunomodulation of human peripheral blood mononuclear cell functions by defined lipid fractions of Mycobacterium avium.

Authors:  W W Barrow; J P de Sousa; T L Davis; E L Wright; M Bachelet; N Rastogi
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

8.  Potential drug targets for Mycobacterium avium defined by radiometric drug-inhibitor combination techniques.

Authors:  N Rastogi; K S Goh; E L Wright; W W Barrow
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

9.  Spatial Organization and Recruitment of Non-Specific T Cells May Limit T Cell-Macrophage Interactions Within Mycobacterium tuberculosis Granulomas.

Authors:  Jess A Millar; J Russell Butler; Stephanie Evans; Joshua T Mattila; Jennifer J Linderman; JoAnne L Flynn; Denise E Kirschner
Journal:  Front Immunol       Date:  2021-01-20       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.